These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7087963)

  • 21. Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.
    Saarinen UM; Coccia PF; Gerson SL; Pelley R; Cheung NK
    Cancer Res; 1985 Nov; 45(11 Pt 2):5969-75. PubMed ID: 2414004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophil-mediated killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement.
    McLaren DJ; Ramalho-Pinto FJ
    J Immunol; 1979 Oct; 123(4):1431-8. PubMed ID: 479590
    [No Abstract]   [Full Text] [Related]  

  • 23. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the terminal stages of antibody-complement-mediated killing of a tumor cell. I. Evidence for the existence of an intermediate, T.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 May; 116(5):1272-5. PubMed ID: 178793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between lipid synthesis in tumor cells and their sensitivity to humoral immune attack.
    Schlager SI; Ohanian SH
    Science; 1977 Aug; 197(4305):773-6. PubMed ID: 196331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of protease treatment on the sensitivity of tumor cells to antibody-GPC killing.
    Boyle MD; Ohanian SH; Boros T
    Clin Immunol Immunopathol; 1978 May; 10(1):84-94. PubMed ID: 207478
    [No Abstract]   [Full Text] [Related]  

  • 28. The guinea-pig complement-activating lymphocyte surface component (GPCA): a mouse T-cell marker distinct from Thy-1.
    Kierszenbaum F; Budzko DB
    Immunology; 1981 Feb; 42(2):307-11. PubMed ID: 6970179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular interactions of cells with antibody and complement: influence of metabolic and physical properties of the target on the outcome of humoral immune attack.
    Ohanian SH; Schlager SI; Borsos T
    Contemp Top Mol Immunol; 1978; 7():153-80. PubMed ID: 215378
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the antibodies in normal rabbit serum responsible for the lysis of NK-sensitive target cells.
    Urdal DL; Henney CS
    Mol Immunol; 1982 Apr; 19(4):599-608. PubMed ID: 7087965
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor cell detection method using complement-mediated cytolytic reaction and imaging sensor system.
    Suzuki M; Watanabe N; Tamiya E; Kataoka T; Tokunaga T; Karube I
    Appl Biochem Biotechnol; 1987 Oct; 15(3):191-200. PubMed ID: 3454129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schistosoma mansoni: complement and antibody damage, mediated by human eosinophils and neutrophils, in killing schistosomula in vitro.
    McKean JR; Anwar AR; Kay AB
    Exp Parasitol; 1981 Jun; 51(3):307-17. PubMed ID: 7227485
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement and cell-mediated lysis of haptenated erythrocytes sensitized with oligomers of rabbit IgG antibody.
    Jones JF; Plotz PH; Segal DM
    Mol Immunol; 1979 Nov; 16(11):889-97. PubMed ID: 528016
    [No Abstract]   [Full Text] [Related]  

  • 35. Action of complement in the lysis of mouse sarcoma cells sensitized with H-2 alloantibody.
    Reske-Kunz AB; Scheid MP; Abbott J; Metakis LJ; Polley MJ; Boyse EA
    Transplantation; 1979 Aug; 28(2):149-53. PubMed ID: 483361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of specific lipids associated with the hormone-induced resistance of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1979 Jan; 122(1):108-14. PubMed ID: 762409
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR; Höffken K; Baldwin RW
    Transplantation; 1979 Aug; 28(2):140-3. PubMed ID: 483360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of islet cell surface antibodies and complement on the release of insulin and chromium from perifused beta cells.
    Kanatsuna T; Freedman ZR; Rubenstein AH; Lernmark A
    Clin Exp Immunol; 1982 Jan; 47(1):85-92. PubMed ID: 7047026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell growth-dependent variation in the sensitivity of human and mouse tumor cells to complement-mediated killing.
    Ohanian SH; Yamazaki M; Schlager SI; Faibisch M
    Cancer Res; 1983 Feb; 43(2):491-5. PubMed ID: 6401218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.